Huntington's program (BPGbio)

N/A

Report date: 2025/06/11 10:55:04
NME

Base Information

Drug NameHuntington's program (BPGbio)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUbiquitin-conjugating enzyme E2 K modulators
TargetsUbiquitin-conjugating enzyme E2 K
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBerg Llc
China Registration ClassN/A

Develop Information

Active CompaniesBPGbio Inc
Inactive CompaniesBerg Llc
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A